Trial Profile
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Tivozanib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Mar 2013 New trial record